Marshall Wace’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-30,055
| Closed | -$6.41M | – | 3175 |
|
|
2025
Q4 | $6.41M | Buy |
30,055
+12,357
| +70% | +$2.55M | 0.01% | 1041 |
|
|
2025
Q3 | $3.52M | Sell |
17,698
-99,464
| -85% | -$18.6M | ﹤0.01% | 1350 |
|
|
2025
Q2 | $20.2M | Buy |
117,162
+94,868
| +426% | +$15.5M | 0.02% | 581 |
|
|
2025
Q1 | $3.47M | Sell |
22,294
-91,951
| -80% | -$13.1M | ﹤0.01% | 1221 |
|
|
2024
Q4 | $15.7M | Sell |
114,245
-106,830
| -48% | -$14M | 0.02% | 621 |
|
|
2024
Q3 | $33M | Buy |
221,075
+190,786
| +630% | +$25.8M | 0.04% | 370 |
|
|
2024
Q2 | $4.13M | Buy |
30,289
+5,205
| +21% | +$708K | 0.01% | 1083 |
|
|
2024
Q1 | $3.79M | Buy |
+25,084
| New | +$3.58M | 0.01% | 1108 |
|
|
2023
Q2 | – | Sell |
-108,326
| Closed | -$11.6M | – | 2458 |
|
|
2023
Q1 | $11.6M | Buy |
108,326
+4,900
| +5% | +$561K | 0.03% | 659 |
|
|
2022
Q4 | $12.6M | Sell |
103,426
-155,449
| -60% | -$18M | 0.03% | 693 |
|
|
2022
Q3 | $26.7M | Buy |
258,875
+192,159
| +288% | +$18.2M | 0.07% | 359 |
|
|
2022
Q2 | $6.2M | Sell |
66,716
-103,195
| -61% | -$9.73M | 0.01% | 1190 |
|
|
2022
Q1 | $19.9M | Sell |
169,911
-88,159
| -34% | -$10.2M | 0.04% | 499 |
|
|
2021
Q4 | $34.7M | Buy |
258,070
+244,605
| +1,817% | +$36.4M | 0.07% | 305 |
|
|
2021
Q3 | $2.15M | Buy |
+13,465
| New | +$1.84M | 0.01% | 1491 |
|
|
2020
Q2 | – | Sell |
-21,246
| Closed | -$2.39M | – | 1532 |
|
|
2020
Q1 | $2.39M | Buy |
21,246
+19,311
| +998% | +$2.51M | 0.02% | 572 |
|
|
2019
Q4 | $269K | Sell |
1,935
-802
| -29% | -$89.1K | ﹤0.01% | 1304 |
|
|
2019
Q3 | $263K | Buy |
+2,737
| New | +$305K | ﹤0.01% | 1236 |
|
|
2019
Q2 | – | Sell |
-28,948
| Closed | -$3.41M | – | 1338 |
|
|
2019
Q1 | $3.41M | Buy |
28,948
+10,921
| +61% | +$956K | 0.03% | 582 |
|
|
2018
Q4 | $1.13M | Buy |
18,027
+11,789
| +189% | +$741K | 0.01% | 881 |
|
|
2018
Q3 | $442K | Sell |
6,238
-5,520
| -47% | -$380K | ﹤0.01% | 952 |
|
|
2018
Q2 | $782K | Sell |
11,758
-460
| -4% | -$30.3K | 0.01% | 535 |
|
|
2018
Q1 | $799K | Buy |
+12,218
| New | +$687K | 0.03% | 285 |
|
|
2017
Q1 | – | Sell |
-87,558
| Closed | -$1.77M | – | 330 |
|
|
2016
Q4 | $1.77M | Buy |
+87,558
| New | +$1.75M | 0.01% | 665 |
|
Other funds holding ASND
RCM
ACA
